Division of Hematology & Thromboembolism
Shannon Bates is Professor, Medicine and Director
of the Division of Hematology and Thromboembolism.
The Division of Hematology & Thromboembolism at McMaster University is internationally recognized for its excellence in research, education and patient care. Our members are derived not only from the Department of Medicine but also from Pathology & Molecular Medicine, as well as Oncology. We have close ties to our colleagues in the Department of Pediatrics’ Division of Pediatric Hematology/ Oncology. Several of our division members also hold cross-appointments in Health Research Methods, Evidence, and Impact.
The Division of Hematology & Thromboembolism at McMaster University provides clinical care for patients with Hematological disorders at the four acute care sites in Hamilton. Members of the Division provide are also involved in leadership roles in the Hamilton Regional Laboratory Medicine Program (HRLMP).
The Division has an active research programme, and has achieved world-wide recognition for its research in thrombosis and hemostasis, platelet physiology and function, blood transfusion therapy, the molecular biology of red cell disorders and trials in malignant hematologic diseases. The Department of Medicine houses two research organizations devoted to hematology-based research, the Thrombosis and Atherosclerosis Research Institute (TaARI, directed by Dr. Jeffrey Weitz) and the McMaster Centre for Transfusion Research (directed by Dr. Donnie Arnold). Funding for our research comes from a variety of sources, including CIHR, the Heart and Stroke Foundation, and Canadian Blood Services.
Division members make important educational contributions at all levels, including clinical mentorship of medical students, internal medicine residents, residents from other specialty programs, and clinical fellows; as well as supervision at the Masters and PhD level in Health Research Methods, Evidence, and Impact, Biochemistry and Biomedical Sciences. The Division has a highly respected Hematology Residency Program, providing hematology training to residents in the 4th and 5th years of their postgraduate training. Our diverse expertise also allows us to provide unique post-residency opportunities in transfusion medicine, thromboembolism, hemostasis and platelet immunology, malignant hematology, and research methodology. Our faculty are major contributors to the Transfusion Medicine Training Program, which is housed in the Department of Pathology & Molecular Medicine. We will be seeking Royal College approval for an Adult Thrombosis Medicine Area of Focused Competence (AFC) Diploma Program in the fall of 2017.